Title: Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.
Source: Obesity, 2011, 19 (9) p.1796-1803.
Follow this link for abstract.
Date of publication: September, 2011.
Publication type: Research.
In a nutshell: This study examines the effects of a 24-week weight loss program with Orlistat 60mg upon participants’ visceral adipose tissue (VAT) in comparison with placebo. Whilst all participants had significantly reduced their VAT, those taking Orlistat also displayed a greater total fat mass loss and reduction in their intramuscular adipose tissue and liver fat content. These results suggest that Orlistat 60mg may be an effective weight loss tool, particularly in relation to abdominal obesity.
Length of publication: 8 pages.
Some important notes: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.